Cholinergic systems and long-term potentiation in memory-impaired apolipoprotein E-deficient mice

Neuroscience

Volumn 92, Issue 4, 1999, Pages 1273-1286

  Krzywkowski, P ^a   Ghribi, O ^b   Gagne J ^b   Chabot, C ^b   Kar, S ^a   Rochford, J ^a,c   Massicotte, G ^b   Poirier, J ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cholinergic; Cognitive impairment; Glutamatergic; LTP

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; APOLIPOPROTEIN E; CHOLINE ACETYLTRANSFERASE; LIPID; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; NICOTINIC RECEPTOR; PHOSPHOLIPASE A2;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; CONTROLLED STUDY; FOREBRAIN; LONG TERM POTENTIATION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANIMALS; APOLIPOPROTEINS E; AUTORADIOGRAPHY; BRAIN; CHOLINE O-ACETYLTRANSFERASE; GLUTAMIC ACID; HISTOCYTOCHEMISTRY; LONG-TERM POTENTIATION; MAZE LEARNING; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PARASYMPATHETIC NERVOUS SYSTEM; PHOSPHOLIPASES A; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC;

EID: 0033006150     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00061-5     Document Type: Article

References (83)

1. Anderson R., Higgins G.A. Absence of central cholinergic deficits in ApoE knockout mice. Psychopharmacology. 132:1997;135-144.
2. Anderson R., Barnes J.C., Bliss T.V.P., Cain D.P., Cambon K., Davies H.A., Errington M.L., Fellows L.A., Gray R.A., Hoh T., Stewart M., Large C.H., Higgins G.A. Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse. Neuroscience. 85:1998;93-110.
3. Arendt T., Schindler C., Bruckner M.K., Eschrich K., Bigl V., Zedlick D., Marcova L. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein e4 allele. J. Neurosci. 17:1997;516-529.
4. Aubert I., Araujo D.M., Cecyre D., Robitaille Y., Gauthier S., Quirion R. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J. Neurochem. 58:1992;529-541.
5. Aubert I., Cecyre D., Quirion R. Cholinergic markers in aged memory-impaired rats. Neuroscience. 67:1995;277-292.
6. Bartus R.T., Dean R.L., Beer G., Lippa S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-412.
7. Baudry M., Massicotte G. Concepts Neurosci. 3:1992;79-98.
8. Bernard J., Lahsaini A., Massicotte G. Potassium-induced long-term potentiation in area CA1 of the hippocampus involves phospholipase activation. Hippocampus. 4:1994;447-453.
9. Bertrand P., Poirier J., Oda T., Finch C.E., Pasinetti G.M. Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer's disease. Molec. Brain Res. 33:1995;174-178.
10. Bliss T., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
11. Bliss T., Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of anaesthetized rabbit following stimulation of the perforant path. J. Physiol., Lond. 232:1973;331-356.
12. Brown D.A., Abogadie F.C., Allen T.G.J., Buckley N.J., Caufield M.P., Delmas P., Haley J.E., Lamas J.A., Selyanko A.A. Muscarinic mechanisms in nerve cells. Life Sci. 60:1997;1137-1144.
13. Buchs P.A., Muller D. Induction of long-term potentiation is associated with major ultrastructural changes of activated synapses. Proc. natn. Acad. Sci. U.S.A. 93:1996;8040-8045.
14. Davies P., Maloney A.J.F. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 2:1976;1403.
15. Davies S.N., Lester R.A., Reymann K.G., Collingridge G.L. Temporally distinct pre- and post-synaptic mechanisms maintain long-term potentiation. Nature. 338:1989;500-503.
16. Desarno P., Jope R.S. Phosphoinositide hydrolysis activated by muscarinic or glutamatergic, but not adrenergic, receptors is impaired in apoE-deficient mice and by hydrogen peroxide and peroxynitrite. Expl Neurol. 152:1998;123-128.
17. Djik S.N., Francis P.T., Stratmann G.C., Bowen D.M. Cholinomimetics increase glutamate outflow via an action on the corticostriatal pathway: implications for Alzheimer's disease. J. Neurochem. 65:1995;2165-2169.
18. Fagan A.M., Murphy B., Kilbridge J., Mobley W., Schwartz A.L., Bu G., Holtzman D.M. The septo-hippocampal cholinergic system: normal development and aging in apoE knockout mice. Am. Soc. Neurosci. Abstr. 27(861.6):1997;2216.
19. Foster T.C., Gagné J., Massicotte G. Mechanism of altered synaptic strength due to experience: relation to long-term potentiation. Brain Res. 736:1996;243-250.
20. Franklin K. B. J. and Paxinos G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic, New York.
21. Gordon I., Grauer E., Genis I., Sehayek E., Michaelson D.M. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199:1995;1-4.
22. Hollingsworth E.B., McNeal E.T., Burton J.L., Williams R.J., Daly J.W., Creveling C.R. Biochemical characterization of a filtered synaptoneurosome preparation from guinea pig cerebral cortex: cyclic adenosine 3′:5′-monophosphate-generating systems, receptors, and enzymes. J. Neurosci. 5:1985;2240-2253.
23. Isaac J.T.R., Nicoll R.A., Malenka R.C. Evidence for silent synapses: implications for the expression of the LTP. Neuron. 15:1995;427-434.
24. Jerusalinsky D., Kornisiuk E., Izquierdo I. Cholinergic neurotransmission and synaptic plasticity concerning memory processing. Neurochem. Res. 22:1997;507-515.
25. Jones O.T., McNamee M.G. Annular and nonannular binding sites for cholesterol associated with the nicotinic acetylcholine receptor. Biochemistry. 27:1988;2364-2374.
26. Kar S., Seto D., Gaudreau P., Quirion R. β-Amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices. J. Neurosci. 16:1996;1034-1040.
27. Karnovky M.J., Roots L. A direct-coloring thiocholine method for cholinesterase. J. Histochem. Cytochem. 12:1964;219-221.
28. Kim D.K., Rordorff G., Nemenoff R.A., Koroshetz W.J., Bonventre J.V. Glutamate stably enhances the activity of two cytosolic forms of phospholipase A2 in brain cortical cultures. Biochem. J. 310:1995;83-90.
29. Krugers H.J., Mulder M., Korf J., Havekes L.M., deKloet E.R., Joels M. Altered synaptic plasticity in hippocampal CA1 area of apolipoprotein E-deficient mice. NeuroReport. 8:1997;2505-2510.
30. Ladner C., Celesia G.G., Magnuson D., Lee J.M. Regional alterations in M1 muscarinic receptor G-protein coupling in Alzheimer's disease. J. Neuropath. exp. Neurol. 54:1995;783-789.
31. LaDu M.J., Falduto M.T., Manelli A.M., Reardon C.A., Getz G.S., Frail D.E. Isoform-specific binding of apolipoprotein E to beta-amyloid. J. biol. Chem. 269:1994;23,403-23,406.
32. Lao D., Hassle N.A., Malinow R. Activation of postsynaptically silent synapses during pairing-induced LTP in CA1 region of hippocampal slice. Nature. 375:1995;400-404.
33. Larson J., Lynch G. Role of N-methyl-D-aspartate receptors in the induction of synaptic potentiation by burst stimulation patterned after the hippocampal theta-rhythm. Brain Res. 441:1988;111-118.
34. Levey A.I., Edmunds S.M., Koliatsos V., Wiley R.G., Heilman C.J. Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation. J. Neurosci. 15:1995;4077-4092.
35. Lisman J., Malenka R.C., Nicoll R.A., Malinow R. Learning mechanisms: the case for CaM-KII. Science. 276:1997;2001-2002.
36. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
37. Mash D.G., Flynn D.D., Potter L.T. Loss of M2 muscarine receptors in the cerebral cortex of Alzheimer's disease and experimental cholinergic denervation. Science. 228:1985;1115-1117.
38. Masliah E., Mallory M., Ge N.F., Alford M., Veinbergs I., Roses A.D. Neurodegeneration in the central nervous system of apoE-deficient mice. Expl Neurol. 136:1995;107-122.
39. Massicotte G., Beaudry M. Triggers and substrates of hippocampal synaptic plasticity. Neurosci. biobehav. Rev. 15(3):1991;415-423.
40. Massicotte G., Oliver M.W., Lynch G., Beaudry M. Effect of bromophenacyl bromide, a phospholipase A2 inhibitor, on the induction and maintenance of LTP in hippocampal slices. Brain Res. 537:1990;49-53.
41. Massicotte G., Vanderklish P., Lynch G., Baudry M. Modulation of AMPA/quisqualate receptors by phospholipase A2: a necessary step in long-term potentiation. Proc. natn. Acad. Sci. U.S.A. 88:1991;1893-1897.
42. Molinari S., Battini R., Ferrai S., Pozzi L., Killcross A.S., Robbins T.W., Jouvenceau A., Billard J.M., Dutar P., Lamour Y., Baker W.A., Cox H., Emson P.C. Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expression. Proc. natn. Acad. Sci. U.S.A. 93:1996;8028-8033.
43. Morris R.G., Garrud P., Rawlins J.N.P., O'Keefe J. Place navigation is impaired in rats with hippocampal lesion. Nature. 297:1982;681-683.
44. Nalbantoglu J., Tirado-Santiago G., Lahsaini A., Poirier J., Goncalves O., Verges G., Momoli F., Welner S.A., Massicotte G., Julien J., Shapiro M.L. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature. 387:1997;500-505.
45. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and Kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:1991;163-166.
46. Narang N., Joseph J., Ayyagari P.V., Gerber M., Crews F.T. Age-related loss of cholinergic-muscarinic coupling to PLC: comparison with changes in brain regional PLC subtypes mRNA distribution. Brain Res. 708:1996;143-152.
47. Nitsch R.M., Blusztajn J.K., Pitas A.G., Slack B.E., Growdon J.H., Wurtman R.J. Evidence for a membrane defect in Alzheimer disease brain. Proc. natn. Acad. Sci. U.S.A. 89:1992;1671-1675.
48. 3H]acetylcholine binding sites in the frontal cortex of Alzheimer brain. Neurosci. Lett. 72:1986;115-119.
49. Ohm T.G., Kirca M., Bohl J., Scharnagl H., Gross W., Marz W. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience. 66:1995;583-587.
50. Oitzl M.S., Mulder M., Lucassen P.J., Havekes L.M., Grootendorst J., deKloet E.R. Severe learning deficits in apolipoprotein E-knockout mice in a water maze task. Brain Res. 752:1997;189-196.
51. Okada D., Yamagishi S., Sugiyama H. Differential effects of phospholipase inhibitors on long-term potentiation in rat hippocampal mossy fibers synapses and Schaffer/commissural synapses. Neurosci. Lett. 100:1989;141-146.
52. Parker C.A., Callahan M.J., Lipinski W.J., Bisgaier C.L., Walker L.C. Effect of aging on glial and neural markers in apolipoprotein E-deficient mice. Am. Soc. Neurosci. Abstr. 26(86.3):1996;207.
53. Perry E.K., Gibson P.H., Blessed G., Perry R.H., Tomlinson B.E. Neurotransmitter abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J. neurol. Sci. 34:1977;247-265.
54. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17:1994;525-530.
55. Poirier J. (1997) Neurobiology of apolipoprotein E in the normal brain and in Alzheimer's disease. In Alzheimer's disease: Biology, Diagnosis and Therapeutics (eds Iqbal K., Winblad B., Nishimura T., Takeda M. and Wisniewski H. M.), pp. 93-101. Wiley, New York.
56. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 342:1993;697-699.
57. Poirier J., Delisle M.C., Quirion R., Aubert I., Farlow M.R., Lahiri D., Hui S., Bertrand P., Nalbantoglu J., Gilfix B.M., Gauthier S. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease. Proc. natn. Acad. Sci. U.S.A. 92:1995;12,260-12,264.
58. Poirier J., Delisle M. C., Quirion R., Aubert I., Rochford J., Rousse I., Gracon S., Farlow M. R. and Gauthier S. (1996) Apolipoprotein E4, cholinergic integrity, synaptic plasticity and Alzheimer's disease. In Apolipoprotein E and Alzheimer's disease (eds Roses A. D., Weisgraber K. H. and Christen Y.), pp. 20-28. Springer, Berlin.
59. Quirion R. Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release. J. psychiat. Neurosci. 18:1993;226-234.
60. Ransmayr G., Cervera P., Hirsch E., Ruberg M., Hersh L.B., Duyckaerts C., Hauw J.J., Delumeau C., Agid Y. Choline acetyltransferase-like immunoreactivity in the hippocampal formation of control subjects and patients with Alzheimer's disease. Neuroscience. 32:1989;701-714.
61. Ray P., Berman J.D., Middleton W., Brendle J. Botulinum toxin inhibits arachidonic acid release associated with acetylcholine release from PC12 cells. J. biol. Chem. 268:1993;11,057-11,064.
62. Rebeck G.W., Reiter J.S., Strickland D.K., Hyman B.T. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 11:1993;575-580.
63. Richard F., Helbecque N., Neuman E., Guez D., Levy R., Amouyel P. ApoE genotyping and response to drug treatment in Alzheimer's disease. Lancet. 349:1997;539.
64. Richey P.L., Siedlak S.L., Smith M.A., Perry G. Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis. Biochem. biophys. Res. Commun. 208:1995;657-663.
65. Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., Pericak-Vance M.A., Goldgaber D., Roses A.D. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. natn. Acad. Sci. U.S.A. 90:1993;9649-9653.
66. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Analyt. Biochem. 150:1985;76-85.
67. Soininen H., Kosunen O., Helisalmi S., Mannermaa A., Paljarvi L., Talasniemi S., Ryynanen M., Riekkinen P. Sr. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele. Neurosci. Lett. 187:1995;79-82.
68. Soininen H., Riekkinen P.J. Apolipoprotein E, memory and Alzheimer's disease. Trends Neurosci. 19:1996;224-227.
69. Staubli U., Perez Y., Xu F.B., Rogers G., Ingvar M., Stone-Elander S., Lynch G. Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo. Proc. natn. Acad. Sci. U.S.A. 91:1994;11,158-11,162.
70. Staubli U., Larson J., Lynch G. Mossy fiber potentiation and long-term potentiation involve different expression mechanisms. Synapse. 5:1990;333-335.
71. Strittmatter W.J., Saunders A.M., Schmechel D.E., Pericak-Vance M.A., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc. natn. Acad. Sci. U.S.A. 90:1993;1977-1981.
72. Strittmatter W.J., Saunders A.M., Goedert M., Weisgraber K.H., Dong L.M., Jakes R., Huang D.Y., Pericak-Vance M., Schmechel D., Roses A.D. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc. natn. Acad. Sci. U.S.A. 91:1994;11,183-11,186.
73. Svennerholm L., Gottfries C.G. Membrane lipids, selectivity diminished in Alzheimer's disease brains, suggest synapse loss as a primary event in early-onset form (type II). J. Neurochem. 62:1994;1039-1047.
74. 3H-AMPA binding in rat hippocampus. Brain Res. 573:1992;228-234.
75. Tocco G., Massicotte G., Standley S., Thompson R.F., Baudry M. Phospholipase A2-induced changes in AMPA receptor: an autoradiographic study. NeuroReport. 3:1992;515-518.
76. Tucek S. (1978) Choline acetyltransferase. In Acetylcholine Synthesis in Neurons. pp. 1-258. Chapman and Hall, London.
77. Veinberg I., Jung M.W., Young S.J., Vanuden E., Groves P.M., Masliah E. Altered long-term potentiation in the hippocampus of apolipoprotein E-deficient mice. Neurosci. Lett. 249:1998;71-74.
78. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., Delon M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1982;1237-1239.
79. Wisniewski T., Frangione B. Apolipoprotein E: a pathological chaperone protein in patients cerebral and systemic amyloid. Neurosci. Lett. 135:1992;235-238.
80. Wisniewski T., Golabek A., Matsubara E., Ghiso J., Frangione B. Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid. Biochem. biophys. Res. Commun. 192:1993;359-365.
81. Wurtmann R.J. Cholinergic metabolism as a basis for the selective vunerability of cholinergic neurons. Trends Neurosci. 15:1992;117-122.
82. Zalutsky R.A., Nicoll R.A. Comparison of two forms of long-term potentiation in single hippocampal neurons. Science. 248:1990;1619-1624.
83. Zhang L., Ruehr M.L., Dorman R.V. Arachidonic acid and oleoylacetylglycerol induce a synergistic facilitation of Ca(2+)-dependent glutamate release from hippocampal mossy fiber nerve endings. J. Neurochem. 66:1996;177-185.